A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

September 2, 2008

Worsening Depression in Four Patients on Isentress

Four patients who switched to a regimen containing Isentress (raltegravir) had a temporary worsening of preexisting depression, according to a letter in the September 12 issue of AIDS that was reported by aidsmap.com.

The safety and efficacy results of several clinical trials of Isentress, Merck’s HIV integrase inhibitor, have been published in journals and presented at medical conferences during the past two years. Thus far, no psychiatric side effects from Isentress have been reported in those clinical trials. Because most early studies of new drugs exclude people with serious underlying psychiatric problems, however, no data have been published on the use of Isentress in people being treated for depression and other mental illnesses.

Marianne Harris, MD, and her colleagues from the AIDS Research Program at St. Paul’s Hospital in Vancouver, Canada, report on four cases of people living with HIV, who had sudden and significant worsening of depression for at least one month after starting Isentress. All four patients were men, and ranged in age from 40 to 55. Each had a history of significant clinical depression, and all were taking medication to treat their depression at the time that they started Isentress.

In each case, the men experienced a sudden onset of serious depression in the first few weeks after starting Isentress. One man’s depression was so severe that he needed to be hospitalized. The men’s health care providers made adjustments to their psychiatric medication, and the depressive symptoms in each man then improved within about 60 days. All the men remained on Isentress during this period.

Dr. Harris’s team claims that they have ruled out other potential causes of the depressive symptoms and feels confident that Isentress was the cause. The authors suggest that there may be some kind of drug interaction between Isentress and psychiatric medications, though no known mechanism has been identified. They encourage health care providers of HIV-positive people being treated for serious mental illness to use caution when initiating treatment with Isentress.

Search: Isentress, raltegravir, depression, mental illness, Marianne Harris, St. Paul's Hospital


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 5 (of 5 total)    

Daniel, , 2008-09-18 08:57:39
I am in a Phase IV study of Isentress and Epzicom. I am sure Isentress is the cause of my anxiety and heightened nerve sensitivity. My nerves feel raw and exposed. The smallest upset can drive me into a rage. I am an optimistic person, but my thoughts can turn extremely pessimistic at the slightest upset. Poz since the 80's; treatment naive until now. VL undetectable at 2 weeks and t-cells increased by 100 at 4 weeks. Waiting for results at 2 months.

Rich S., St. Louis, 2008-09-04 02:57:53
I started Isentess just over 2 weeks ago. I have had a very bad week. I thought (and maybe it is) just me. I even checked my pill boxes to to make sure I had taken my Cymbalta and haven't missed a dose. Now I know to be on gaurd. It wouldn't be the first time we found side effects missed in the trials. I'm just gratefull for the medicine and the AIDSmeds team, keep keeping us informed.

joey gonzales, albuquerque, 2008-09-03 14:33:52
I had to get off my anti-depression meds. because I was having seizures, after I was taken off zoloft and effexor I never had a sezure again.

JJBear, Phoenix, 2008-09-03 10:44:59
Insetress interacted with my Dylantin to push it to toxic level after Dylantin was lowered, My depresssion has increased. I do all I can to stay off anti depresant medications. Antidepresants act like a sledge hammer and change none of the life situations that are factors, count me as a double, go figure it brought me to undetectable again when my PI regimin stopped working, but makes my life suck harder

edward boss, Paris, TX, 2008-09-03 00:04:01
I have took Isentress, Intellence, Prezista and Norvir for six mo,after resistance. In one month my viral load went from 215,000 to 60. No increased depression other than having to cut my anti depressant Wellburtron, and clozapam in half because of the booster Norvir. Lithium is processed strickly threw kidneys. Sustiva did cause extream depression on sec. regium.

comments 1 - 5 (of 5 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    chrisf
    san jose
    California


    sequoiamv
    San Jose
    California


    sefarady
    Los Angeles
    California


    burke42
    Albany
    New York
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.